Call Us Now
 
Facebook-f Instagram Linkedin-in
CONTACT US
LOGIN

Moxifloxacin Gel Eye Drops in Chennai: Advanced Ophthalmic Antibiotic Formulation

Moxifloxacin Gel Eye Drops for Chennai's Ophthalmic Market

Chennai has a well-established healthcare ecosystem supported by hospitals, ophthalmology centres, specialist practitioners, pharmacies and pharmaceutical distribution networks. Within this environment, specialized ophthalmic products from EyeKare Kilitch require clearly defined formulations, controlled manufacturing and dependable supply. Antibiotic eye drops form an important part of ophthalmic portfolios, particularly where businesses need products with specific composition, dosage form and packaging characteristics. 

EyeKare Kilitch lists MOXIEYE GEL as Moxifloxacin Eye Drops within its ophthalmic product portfolio. Its official material describes the formulation as Moxifloxacin Hydrochloride IP equivalent to Moxifloxacin 0.5% w/v, with a sterile aqueous base and no added preservatives. For organizations researching Moxifloxacin Gel Eye Drops in Chennai, MOXIEYE GEL provides a clearly identified product within EyeKare’s antibiotic range.

Understanding Moxifloxacin Gel Eye Drops

EyeKare’s Moxieye Gel material explains that Moxifloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes involved in bacterial DNA replication and cell division. The product is positioned for bacterial eye infections and post-operative infection prevention in the company’s published material.  

The gel format distinguishes MOXIEYE GEL from conventional aqueous eye drops. EyeKare states that the formulation has enhanced viscosity, with viscosity of at least 250 centipoise, helping it remain on the ocular surface longer. This formulation characteristic is presented as supporting prolonged ocular retention and sustained therapeutic action. 

MOXIEYE GEL: EyeKare's Moxifloxacin Formulation

MOXIEYE GEL is listed in EyeKare’s official product catalogue alongside other Moxifloxacin products, including MOXIEYE, Moxieye-PFS and combination formulations. The product listing identifies MOXIEYE GEL specifically as Moxifloxacin Eye Drops, while EyeKare’s detailed article provides additional formulation information about the gel technology. 

The published composition specifies Moxifloxacin Hydrochloride IP equivalent to Moxifloxacin 0.5% w/v and a sterile aqueous base. The same material describes the product as self-preserved with no added preservatives. These specifications provide procurement teams with clear attributes to consider when comparing ophthalmic antibiotic products. 

How Gel Drop Technology Supports Ophthalmic Delivery

EyeKare identifies Gel Drop Technology as one of its ophthalmic innovations. The company’s website explains that the technology is intended to overcome limitations associated with oil or paraffin-based ointments and administration difficulties, while allowing formulations with different viscosity levels depending on intended use. It states that gel drops can provide retention comparable to ointment while supporting day and night application. 

For businesses evaluating ophthalmic products, gel technology can therefore be considered as part of the overall dosage-form profile. Viscosity, ocular retention, ease of administration, packaging and stability all contribute to how a formulation is positioned. These factors should be assessed using current product information and regulatory documentation. 

Moxifloxacin Gel for Bacterial Eye-Care Applications

EyeKare’s published Moxieye Gel article identifies bacterial conjunctivitis and post-surgical infection prevention among the product’s stated applications. It also describes the formulation as intended for topical ophthalmic use. Because antibiotic treatment should be based on an appropriate diagnosis and professional direction, product information should not be treated as a substitute for medical advice. 

For pharmaceutical businesses, accurate positioning is equally important. The active ingredient, strength, dosage form, intended use and approved information should be communicated consistently across product materials. This helps distributors, pharmacies and healthcare partners understand exactly which formulation is being supplied. 

Manufacturing and Quality Considerations

Ophthalmic manufacturing requires attention to formulation accuracy, sterility, packaging and contamination control because the product is applied directly to the eye. EyeKare Kilitch states that its products are manufactured in-house at a world-class facility spread across 3,50,000 square feet and describes the facility as compliant with international standards. 

The company also highlights more than 50 qualified scientists working in research and development and quality control. For organizations evaluating a Moxifloxacin supplier, manufacturing infrastructure, quality systems, documentation and supply consistency are useful areas to review.  

What to Consider When Selecting Moxifloxacin Gel Eye Drops

Confirm the Moxifloxacin Strength 

MOXIEYE GEL is described with Moxifloxacin Hydrochloride equivalent to Moxifloxacin 0.5% w/v. Confirming the exact strength and composition against current product documentation is an essential procurement step. 

Review the Gel Formulation 

EyeKare describes Moxieye Gel as having viscosity of at least 250 centipoise. This differentiates the product from conventional low-viscosity drops and is an important formulation characteristic for businesses comparing dosage forms. 

Assess the Manufacturer 

A specialist ophthalmic manufacturer should be evaluated through its manufacturing capabilities, quality controls, product portfolio, technical documentation, packaging systems and ability to support reliable supply. This provides a broader basis for supplier selection. 

EyeKare's Broader Moxifloxacin Portfolio

EyeKare’s product catalogue includes several Moxifloxacin-based products. These include MOXIEYE GEL, standard MOXIEYE Moxifloxacin Hydrochloride Ophthalmic Solution 0.5% w/v, Moxieye-PFS and combination products such as MOXIEYE K and MOXIEYE-D. This range allows businesses to compare different ophthalmic formulations within a specialized portfolio. 

Businesses can review the EyeKare ophthalmic product portfolio to compare MOXIEYE GEL with other Moxifloxacin formulations and related ophthalmic products. A broader portfolio review can support procurement planning for hospitals, clinics and distributors. 

Supporting Ophthalmic Procurement in Chennai

Chennai’s network of hospitals, eye-care clinics, pharmacies and pharmaceutical distributors creates demand for specialized ophthalmic formulations. For businesses serving these channels, products with clearly documented composition and dosage-form characteristics can make portfolio evaluation more structured. 

MOXIEYE GEL offers a distinct gel-based Moxifloxacin formulation that businesses can evaluate alongside conventional Moxifloxacin eye drops. Its published 0.5% w/v strength, enhanced-viscosity positioning and self-preserved formulation provide specific attributes for technical and commercial assessment. 

Why Consider EyeKare Kilitch for Moxifloxacin Gel?

EyeKare Kilitch offers MOXIEYE GEL as a specialized Moxifloxacin ophthalmic formulation and highlights Gel Drop Technology as part of its innovation platform. Its broader Moxifloxacin range and stated in-house manufacturing capabilities provide additional factors for businesses considering an ophthalmic supplier.  

For organizations evaluating MOXIEYE GEL Moxifloxacin Eye Drops, the 0.5% w/v Moxifloxacin strength, gel-based format, enhanced viscosity and self-preserved positioning are relevant product attributes to review. Final procurement decisions should rely on approved documentation and applicable professional and regulatory requirements. 

Conclusion

Moxifloxacin Gel Eye Drops provide an alternative dosage-form approach to conventional antibiotic ophthalmic drops. EyeKare lists MOXIEYE GEL in its product catalogue, while its published product material describes Moxifloxacin 0.5% w/v, enhanced viscosity of at least 250 centipoise and a self-preserved formulation with no added preservatives. 

For businesses searching for Moxifloxacin Gel Eye Drops in Chennai, EyeKare Kilitch offers MOXIEYE GEL within its ophthalmology-focused portfolio. Its defined composition, gel technology and stated manufacturing capabilities provide relevant factors for product and supplier evaluation. 

Subscribe Our News Letter!

Subscribe to the EyeCare newsletter to receive updates on the latest developments, events and innovations in ophthalmology.

EyeKare Kilitch  is an innovative pharmaceutical company that discovers, develop, manufactures and market a broad range of healthcare products.

Facebook-f Instagram

Useful links

Contact Us

+91-22-6137 2222

info@eyekare.in

902-B, Godrej Coliseum, Behind Everard Nagar, Off. Eastern Express Highway, Nr. Priyadarshani Circle, Sion (E.), Mumbai - 400 022. INDIA.

© Copyright 2024 – EyeKareKilitch

Group of Companies